910568-52-4Relevant academic research and scientific papers
4,4,5,5, Tetrasubstituted imidazolines
-
Page/Page column 34/1, (2008/06/13)
There is provided a compound of formula I and the pharmaceutically acceptable salts and esters thereof wherein X1, X2, R1, R2, R3, R4, R5 and R6 are herein described. The compounds exhibit activity as anticancer agents.
Cis-imidazolines
-
Page/Page column 17, (2008/06/13)
There are presented compounds of the formula or pharmaceutically acceptable salts thereof, wherein Y1, Y2, X1, X2, X3 and R are as described in this application. These compounds are believed to inhibit MDM2-p53 interaction and as such the compounds will have anti-hyperproliferative cellular activity.
